Second-Line  VEGFR  TKI  Outcomes  After  First-Line  Immune  Checkpoint  Blockade  in  Metastatic  Renal  Cell  Carcinoma

Second-Line VEGFR TKI Outcomes After First-Line Immune Checkpoint Blockade in Metastatic Renal Cell Carcinoma

User Photo
kidneycancer

1 year
234 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ritesh Kotecha discusses Second-Line VEGFR TKI Outcomes After First-Line Immune Checkpoint Blockade in Metastatic Renal Cell Carcinoma at the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.
Up Next Autoplay
User Photo